The Procedures for the Review and Approval of Conditional Drug Listing Applications (Trial) was issued on Jul.08, 2020. It aims to promote the implementation of the Drug Registration Administration Measures, which includes relevant policies, regulations, and measures.
- Local Title:药品附条件批准上市申请审评审批工作程序（试行）
- Country/Region:Chinese Mainland
- Competent Authority: National Medical Products Administration (NMPA)
- Type:Regulation
- Status:In force
- Release Date:2020-07-08
- Implementation Date:2020-07-08